Curtana Pharmaceuticals

0 followers


Curtana Pharmaceuticals is a privately-held, preclinical-stage biopharmaceutical company developing first-in-class, small molecule therapeutics that are highly specific for cancer stem cells in the central nervous system (CNS) for the treatment of glioblastoma (GBM) and other brain cancers.

Employees

1-10

Links

Org chart

Gregory Stein

Collapse
David M. Weiner
Chief Medical Officer
Michelle Rose
VP, Regulatory Affairs
Lawrence J. Trost
VP, Toxicology & Nonclinical Development
Mark Sorenson
Head, CMC Development
Daniel Pertschuk
Consultant, Clinical Development
Fabio Tucci
Co-founder